Health, Rights and Drugs: Harm Reduction, Decriminalization and Zero Discrimination for People who Use Drugs. UNAIDS. (2019)

immage

The new UNAIDS report, Health, rights and drugs: harm reduction, decriminalization and zero discrimination for people who use drugs, shows that of the 10.6 million people who inject drugs in 2016, more than half were living with hepatitis C and one in eight were living with HIV. It outlines that ensuring that comprehensive harm reduction services are available—including needle–syringe programmes, drug dependence treatment and HIV testing and treatment—will kick-start progress on stopping new HIV infections among people who use drugs.


Keywords: HIV, drugs, harm reduction, human rights, discrimination

 

Download Publication

IDPC analysis of the UNODC World Drug Report 2018. International Drug Policy Consortium (IDPC). (2019)

immage

Almost a decade ago, the international community agreed upon a Political Declaration and Plan of Action on International Cooperation towards an Integrated and Balanced Strategy to Counter the World Drug Problem. The Declaration included the decision to establish 2019 as the target date for the goals set within it, specifically for states to ‘eliminate or reduce significantly and measurably’ the illicit cultivation, production, trafficking and use of internationally controlled substances, the diversion of precursors and money laundering. 


Keywords: drug dependence treatment, indicators, harm reduction, treatment

 

Download Publication

International Guidelines on Human Rights and Drug Policy. UNDP. (2019)

immage

Drug control intersects with much of the 2030 Agenda for Sustainable Development and the UN Member State pledge to leave no one behind. In line with the 2030 Agenda, the UNDP Strategic Plan 2018-2021 and the HIV, Health and Development Strategy 2016-2021: Connecting the Dots, the International Guidelines on Human Rights and Drug Policy  provide a comprehensive set of international legal standards for placing human dignity and sustainable development at the centre of Member State responses to illicit drug economies. The guidelines cover a diverse set of substantive issues ranging from development to criminal justice to public health.


Keywords: HIV, human rights, drugs, women, children

 

Download Publication

Myanmar Integrated Biological and Behavioural Surveillance Survey and Population Size Estimates among People Who Inject Drugs (PWID) 2017-2018. National AIDS Programme and Ministry of Health of Sports Myanmar (2019)

immage

This report presents the results of the 2017-18 Integrated Biological and Behavioural Survey (IBBS), among people who inject drugs (PWID) in selected sites in Myanmar, including a formative assessment and population size estimations. A formative assessment was conducted in September 2017 in each site to inform the implementation of the IBBS. The assessment was conducted to assess the particulars of PWID populations in each setting, to provide information to tailor RDS and PSE methods and logistic approaches to the different PWID population and epidemic context.


Keywords: HIV, PWID, hepatitis, care and treatment, prevalence 

 

Download Publication

The Death Penalty for Drug Offences: Global Overview 2018. Girelli G. (2019)

immage

The 2018 Global Overview outlines key trends across the at least 35 countries that retain the death penalty for drug offences in law, and analyses data on death sentences and executions from the last decade. Extensive examination is provided on the divergent trends witnessed in 2018 of falling execution numbers globally, and rising appeal for reimplementation of the death penalty in some countries, while considering the role public opinion plays in all of this.


Keywords: human rights, death panalty, justice, harm reduction

 

Download Publication

2018 World AIDS Day Fact Sheets. National Centre for AIDS and STD Control. (2018)

immage

Find HIV data on HIV epidemic update, epidemic update, HIV testing and counseling, Sexually Transmitted Infections (STIs), Prevention of Mother to Child Transmission (PMTCT), HIV Care and Antiretroviral Therapy (ART) Services and key populations.

 


Keywords: Nepal, STIs, PMTCT, ART, PWID, sex worker, migrant, MSM

 

 

Download Fact Sheets

ASEAN and HIV Prevention amongst People who Inject Drugs: The Need for an Effective and Sustainable Response. Phillips SK. (2018)

immage

Between 2010 and 2016, Asia and the Pacific registered one of the steepest declines in HIV infecti ons globally, with prevalence rates dropping by approximately 13%. Despite this overall reduction, HIV prevalence among people who inject drugs in  Southeast Asia remains among the world’s highest. Regionally, seven of the ten countries with the highest rates of HIV among people who inject drugs are member states of the Association of Southeast Asian Nations (ASEAN).


Keywords: HIV, AIDS, PWID, harm reduction, drugs

 

Download Publication

Briefing Paper: Drug Dependence Treatment in Thailand. Tanguay P and Ngammee V. (2018)

immage

This paper offers a brief analysis of these two challenges in light of current policies and practices, along with recommendati ons for overcoming them to ensure the implementati on of a drug treatment system that can result in improved health and human rights outcomes for people who use drugs and people dependant on drugs.

 


Keywords: drug, treatment, human rights, services
 

 

Download Publication

Ending AIDS among People who Use Drugs - Our Theory of Change. The International HIV/AIDS Alliance. (2018)

immage

The document sets out the changes we want to achieve for people who use drugs, the responses we will make to achieve these changes, the desired outcomes, and the preconditions that need to be in place for the changes to occur.

 


Keywords: harm reduction, drugs, prevention, treatment

 

 

 

Download Publication

Ending an Epidemic: Prioritizing People who Inject Drugs in HCV Elimination Efforts. International AIDS Society (IAS). (2018)

immage

Nearly a quarter of the world’s new HCV infections occur among people who inject drugs (PWID): lack of access to sterile needles, syringes and other injection equipment renders them highly vulnerable to HCV. Legal and structural barriers also greatly increase HCV risk among PWID. Worldwide, more than 50% of the 15.6 million PWID are HCV antibody positive. Without urgent, strategic and measurable action that includes PWID, HCV will continue to inflict a staggering, and increasing, burden of preventable illness and death among families, communities and countries. 


Keywords: PWID, HCV, HIV,  treatment, harm reduction

 

Download Publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Apr
7
(7 Apr - 7 Apr)
May
17
(17 May - 17 May)
May
18
(18 May - 18 May)